These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22010537)

  • 1. Utility of thymosin alpha-1 (Zadaxin) as a co-adjuvant in influenza vaccines: a review.
    Panatto D; Amicizia D; Lai PL; Camerini R; De Rosa A; Gasparini R
    J Prev Med Hyg; 2011 Sep; 52(3):111-5. PubMed ID: 22010537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study.
    Carraro G; Naso A; Montomoli E; Gasparini R; Camerini R; Panatto D; Tineo MC; De Giorgi L; Piccirella S; Khadang B; Ceracchi M; De Rosa A
    Vaccine; 2012 Feb; 30(6):1170-80. PubMed ID: 22178096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymosin α1 continues to show promise as an enhancer for vaccine response.
    Tuthill C; Rios I; De Rosa A; Camerini R
    Ann N Y Acad Sci; 2012 Oct; 1270():21-7. PubMed ID: 23050813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymosin alpha1. SciClone Pharmaceuticals.
    Billich A
    Curr Opin Investig Drugs; 2002 May; 3(5):698-707. PubMed ID: 12090542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymosin alpha 1 as an adjunct to influenza vaccination in the elderly: rationale and trial summaries.
    Ershler WB; Gravenstein S; Geloo ZS
    Ann N Y Acad Sci; 2007 Sep; 1112():375-84. PubMed ID: 17600281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity in Swine of Orally Administered Recombinant Lactobacillus plantarum Expressing Classical Swine Fever Virus E2 Protein in Conjunction with Thymosin α-1 as an Adjuvant.
    Xu YG; Guan XT; Liu ZM; Tian CY; Cui LC
    Appl Environ Microbiol; 2015 Jun; 81(11):3745-52. PubMed ID: 25819954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical studies with IRX-2 and thymosin alpha1 in combination therapy.
    Naylor PH; Hadden JW
    Ann N Y Acad Sci; 2010 Apr; 1194():162-8. PubMed ID: 20536465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza and aging: age-related changes and the effects of thymosin on the antibody response to influenza vaccine.
    Ershler WB; Moore AL; Socinski MA
    J Clin Immunol; 1984 Nov; 4(6):445-54. PubMed ID: 6334692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The modulation of thymosin alpha 1 in the maturation, differentiation and function of murine bone marrow-derived dendritic cells in the absence or presence of tumor necrosis factor-alpha.
    Huang Y; Chen Z; Zhou C; Yao H; Li M; Xu C
    Int Immunopharmacol; 2004 Apr; 4(4):539-46. PubMed ID: 15099531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of virosomal adjuvated influenza vaccines: a review of the literature.
    Gasparini R; Lai P
    J Prev Med Hyg; 2010 Mar; 51(1):1-6. PubMed ID: 20853669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adults.
    McElhaney JE; Coler RN; Baldwin SL
    Expert Rev Vaccines; 2013 Jul; 12(7):759-66. PubMed ID: 23885821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk.
    Durando P; Icardi G; Ansaldi F
    Expert Opin Biol Ther; 2010 Apr; 10(4):639-51. PubMed ID: 20218923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory and enhanced antitumor activity of a modified thymosin α1 in melanoma and lung cancer.
    Wang F; Li B; Fu P; Li Q; Zheng H; Lao X
    Int J Pharm; 2018 Aug; 547(1-2):611-620. PubMed ID: 29933059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymosin α1 as a stimulatory agent of innate cell-mediated immune response.
    Serafino A; Pierimarchi P; Pica F; Andreola F; Gaziano R; Moroni N; Zonfrillo M; Sinibaldi-Vallebona P; Garaci E
    Ann N Y Acad Sci; 2012 Oct; 1270():13-20. PubMed ID: 23050812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between a conventional subunit vaccine and the MF59-adjuvanted subunit influenza vaccine in the elderly: an evaluation of the safety, tolerability and immunogenicity.
    Sindoni D; La Fauci V; Squeri R; Cannavò G; Bacilieri S; Panatto D; Gasparini R; Amicizia D
    J Prev Med Hyg; 2009 Jun; 50(2):121-6. PubMed ID: 20099444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvanted influenza vaccines.
    Even-Or O; Samira S; Ellis R; Kedar E; Barenholz Y
    Expert Rev Vaccines; 2013 Sep; 12(9):1095-108. PubMed ID: 24053401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.
    van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Vogelzang-van Trierum SE; Nieuwkoop NJ; van de Vijver DA; Fouchier RA; Osterhaus AD; Morein B; Rimmelzwaan GF
    Vaccine; 2014 Sep; 32(43):5614-23. PubMed ID: 25140929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jack of all trades: thymosin α1 and its pleiotropy.
    Romani L; Moretti S; Fallarino F; Bozza S; Ruggeri L; Casagrande A; Aversa F; Bistoni F; Velardi A; Garaci E
    Ann N Y Acad Sci; 2012 Oct; 1269():1-6. PubMed ID: 23045964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of adjuvants in vaccines for seasonal and pandemic influenza.
    Brown LE
    Vaccine; 2010 Nov; 28(50):8043-5. PubMed ID: 20849874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymosin alpha 1: biological activities, applications and genetic engineering production.
    Li J; Liu CH; Wang FS
    Peptides; 2010 Nov; 31(11):2151-8. PubMed ID: 20699109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.